Literature DB >> 33780946

MASP-1 and MASP-3 Bind Directly to Aspergillus fumigatus and Promote Complement Activation and Phagocytosis.

Anne Rosbjerg1,2, Reinhard Würzner3, Peter Garred1, Mikkel-Ole Skjoedt1,2.   

Abstract

Activation of the complement system is mediated by the interaction between pathogens and pattern recognition molecules (PRMs); mannose-binding lectin (MBL), ficolins, and collectin-10/-11 from the lectin pathway and C1q from the classical pathway. Lectin pathway activation specifically depends on proteases named MBL-associated serine proteases (MASPs) that are found in complexes with PRMs. In this study, we hypothesize that MASPs can recognize selected pathogens independently of PRMs. Using different clinical strains of opportunistic fungi, we have observed that MASPs directly recognize certain fungal pathogens in a way that can facilitate complement activation. Among these were Aspergillus fumigatus - a dangerous pathogen, especially for immunocompromised patients. In flow cytometry and fluorescence microscopy, we found that MASP-1 and -3 bound to all A. fumigatus growth stages (conidia, germ tubes, and hyphae), whereas rMASP-2 and the nonproteolytic rMAP-1 did not. Bound rMASPs could recruit rMBL and rficolin-3 to A. fumigatus conidia in a nonclassical manner and activate complement via rMASP-2. In experiments using recombinant and purified components, rMASP-1 increased the neutrophilic phagocytosis of conidia. In serum where known complement activation pathways were blocked, phagocytosis could be mediated by rMASP-3. We have encountered an unknown pathway for complement activation and found that MASP-1 and MASP-3 have dual functions as enzymes and as PRMs.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Aspergillosis; Fungi; Lectin pathway; Mannose-binding lectin-associated serine protease; Pattern recognition molecules

Mesh:

Substances:

Year:  2021        PMID: 33780946      PMCID: PMC8460983          DOI: 10.1159/000514546

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  39 in total

1.  The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases.

Authors:  Florence Teillet; Bernard Dublet; Jean-Pierre Andrieu; Christine Gaboriaud; Gérard J Arlaud; Nicole M Thielens
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

2.  Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.

Authors:  Mette Møller-Kristensen; Steffen Thiel; Anders Sjöholm; Misao Matsushita; Jens C Jensenius
Journal:  Int Immunol       Date:  2006-12-20       Impact factor: 4.823

3.  Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function.

Authors:  Márton Megyeri; Veronika Makó; László Beinrohr; Zoltán Doleschall; Zoltán Prohászka; László Cervenak; Péter Závodszky; Péter Gál
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

Review 4.  A journey through the lectin pathway of complement-MBL and beyond.

Authors:  Peter Garred; Ninette Genster; Katrine Pilely; Rafael Bayarri-Olmos; Anne Rosbjerg; Ying Jie Ma; Mikkel-Ole Skjoedt
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 5.  Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?

Authors:  Giulia Dragonetti; Marianna Criscuolo; Luana Fianchi; Livio Pagano
Journal:  Med Mycol       Date:  2016-12-02       Impact factor: 4.076

6.  Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation.

Authors:  Steven G E Braem; Suzan H M Rooijakkers; Kok P M van Kessel; Hans de Cock; Han A B Wösten; Jos A G van Strijp; Pieter-Jan A Haas
Journal:  J Innate Immun       Date:  2015-02-10       Impact factor: 7.349

7.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

8.  MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked.

Authors:  József Dobó; Dávid Szakács; Gábor Oroszlán; Elod Kortvely; Bence Kiss; Eszter Boros; Róbert Szász; Péter Závodszky; Péter Gál; Gábor Pál
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

9.  Complement Nomenclature-Deconvoluted.

Authors:  Suzanne S Bohlson; Peter Garred; Claudia Kemper; Andrea J Tenner
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

10.  Complement C3 plays an essential role in the control of opportunistic fungal infections.

Authors:  S Vicky Tsoni; Ann M Kerrigan; Mohlopheni J Marakalala; Naren Srinivasan; Maureen Duffield; Philip R Taylor; Marina Botto; Chad Steele; Gordon D Brown
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

View more
  3 in total

Review 1.  Emerging roles of the complement system in host-pathogen interactions.

Authors:  Sanjaya K Sahu; Devesha H Kulkarni; Ayse N Ozanturk; Lina Ma; Hrishikesh S Kulkarni
Journal:  Trends Microbiol       Date:  2021-09-29       Impact factor: 17.079

2.  Once Upon a Time.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2021-06-09       Impact factor: 7.349

3.  Surfactant protein D inhibits growth, alters cell surface polysaccharide exposure and immune activation potential of Aspergillus fumigatus.

Authors:  Sarah Sze Wah Wong; Sarah Dellière; Natalia Schiefermeier-Mach; Lukas Lechner; Susanne Perkhofer; Perrine Bomme; Thierry Fontaine; Anders G Schlosser; Grith L Sorensen; Taruna Madan; Uday Kishore; Vishukumar Aimanianda
Journal:  Cell Surf       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.